Stoke Therapeutics, Inc. (STOK) ownership: Top institutional holder: RTW INVESTMENTS, LP ($183.10M). Insider activity: Net Seller (0 buys, 20 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| RTW INVESTMENTS, LP | 5623525.00 | $183.10M | 2026-03-31 |
| BlackRock, Inc. | 5385714.00 | $175.36M | 2026-03-31 |
| FMR LLC | 5383666.00 | $175.29M | 2026-03-31 |
| Lynx1 Capital Management LP | 4763673.00 | $155.11M | 2026-03-31 |
| Redmile Group, LLC | 4164120.00 | $135.58M | 2026-03-31 |
| MORGAN STANLEY | 3423280.00 | $111.46M | 2026-03-31 |
| BAKER BROS. ADVISORS LP | 3336697.00 | $108.64M | 2026-03-31 |
| TORONTO DOMINION BANK | 3173258.00 | $103.32M | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-06-16 | |
| Sell | null | 2026-06-03 | |
| Sell | null | 2026-06-03 | |
| Sell | null | 2026-06-03 | |
| Sell | null | 2026-06-03 | |
| Sell | null | 2026-06-03 | |
| Sell | null | 2026-06-03 | |
| Sell | null | 2026-06-03 |
Back to STOK overview · STOK earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.